Video
Author(s):
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Susan F. Slovin, MD, PhD, medical oncologist, associate vice chair, Academic Affairs, Department of Medicine, Memorial Sloan Kettering Cancer Center, discusses her experience with CAR T-cell therapy as an emerging treatment for patients with prostate cancer.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Study shows persistent bone protective effect of menopausal hormone therapy
Metastasis-directed radiotherapy without systemic therapy yields promising outcomes in oligometastatic ccRCC
Aquablation procedures for prostate cancer completed at ambulatory surgery center
FDA grants priority review to expanded indication of flibanserin in HSDD
2 Commerce Drive
Cranbury, NJ 08512